Healthpeak Properties, Inc. · NYSE (us_market)
Real Estate · REIT - Healthcare Facilities · United States
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical 530 properties; (ii) Lab 139 properties; (iii) CCRC 15 properties; and (iv) Other non-reportable 19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-10-03$19.37 RISE2026-02-12$16.28 PEAK2026-05-11$19.76 220d | -16.0% 132d | Missed | Missed | — | — | +21.4% 88d | Missed |
DROP2025-04-02$20.06 RISE2025-08-11$16.77 PEAK2025-10-03$19.37 184d | -16.4% 131d | Missed | Missed | — | — | +15.5% 53d | Missed |
DROP2025-03-24$20.45 RISE2025-08-01$16.77 PEAK2025-10-03$19.37 193d | -18.0% 130d | Missed | Missed | — | — | +15.5% 63d | Missed |
DROP2024-01-12$20.84 RISE2024-02-26$16.18 PEAK2024-05-15$20.25 124d | -22.4% 45d | 2024-02-02 $18.31 | 2024-04-26 $18.80 | 69Deep Value | 34Watch | +25.2% 79d | +2.7% Held 84d |
DROP2023-07-26$22.21 RISE2023-10-31$15.55 PEAK2024-01-12$20.84 170d | -30.0% 97d | 2023-09-27 $18.05 | 2024-01-12 $20.84 | 69Deep Value | 62Deep Value | +34.0% 73d | +15.5% Held 107d |
DROP2023-02-13$26.49 RISE2023-06-23$19.27 PEAK2023-07-26$22.21 163d | -27.3% 130d | 2023-03-14 $21.56 | 2023-07-26 $22.21 | 63Deep Value | 59Deep Value | +15.3% 33d | +3.0% Held 134d |
DROP2022-06-01$29.33 RISE2022-10-10$21.61 PEAK2023-01-04$26.39 217d | -26.3% 131d | Missed | Missed | — | — | +22.1% 86d | Missed |
DROP2022-04-21$35.40 RISE2022-06-14$23.44 PEAK2022-08-12$28.37 113d | -33.8% 54d | Missed | Missed | — | — | +21.0% 59d | Missed |
DROP2022-01-04$36.66 RISE2022-03-01$30.75 PEAK2022-04-21$35.40 107d | -16.1% 56d | Missed | Missed | — | — | +15.1% 51d | Missed |
DROP2020-02-18$37.33 RISE2020-05-13$21.55 PEAK2020-06-08$29.82 111d | -42.3% 85d | Missed | Missed | — | — | +38.4% 26d | Missed |
DROP2020-02-18$37.33 RISE2020-03-23$19.95 PEAK2020-06-08$29.82 111d | -46.6% 34d | Missed | Missed | — | — | +49.5% 77d | Missed |
It's getting tougher to find S&P 500 dividend stocks that make any sense anymore. Thanks to skyrocketing stock prices, the S&P 500's yield is now less than 1%. Meanwhile, the yield on Vanguard Total Bond Market ETF is up to nearly 4%.
DOC gains 22.7% year-to-date, driven by leasing momentum, rising occupancy and Janus Living growth.
The Invesco S&P 500 High Dividend Low Volatility ETF (NYSEARCA:SPHD) sells the most appealing pitch in income investing: take the highest yielders in the S&P 500, filter for the calmest fifty, collect monthly checks. Over the last five years that pitch delivered 36% in total, or roughly 6% annualized. The SPDR S&P 500 ETF Trust ... SPHD’s High Dividend Low Volatility Promise Has Returned Just 6 Percent Annualized While the S&P 500 Doubled It
Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:DOC) with a Overweight and raises the price target from $18 to $20.
Healthpeak Properties (DOC) has been drawing attention after recent share price moves, with the stock showing double digit total returns over the past year and over the past 3 months, alongside mixed annual revenue and net income trends. See our latest analysis for Healthpeak Properties. The current US$19.66 share price sits against a backdrop of strong recent momentum, with a 30 day share price return of 14.97% and a year to date gain of 21.36%, while the 5 year total shareholder return...
Healthpeak Properties (DOC) has been drawing attention after recent share price moves, with the stock showing double digit total returns over the past year and over the past 3 months, alongside mixed annual revenue and net income trends. See our latest analysis for Healthpeak Properties. The current US$19.66 share price sits against a backdrop of strong recent momentum, with a 30 day share price return of 14.97% and a year to date gain of 21.36%, while the 5 year total shareholder return...
It isn’t easy to find attractive dividend yields right now, and it’s even harder to find high-yielding stocks that don’t look like yield traps. The S&P 500 is up a solid 8.7%, but that growth, along with the popularity of dividend-averse tech stocks, has pushed the yield on the close to 1%—near record lows.
It isn’t easy to find attractive dividend yields right now, and it’s even harder to find high-yielding stocks that don’t look like yield traps. The S&P 500 is up a solid 8.7%, but that growth, along with the popularity of dividend-averse tech stocks, has pushed the yield on the close to 1%—near record lows.
Healthpeak Properties, Inc. (NYSE:DOC) is one of the 10 Fastest Growing S&P 500 Stocks to Buy Now. On May 13, 2026, Baird analyst Wesley Golladay raised the firm’s price target on Healthpeak Properties, Inc. (NYSE:DOC) to $21 from $19 while maintaining an Outperform rating on the shares. The firm updated its model following the company’s […]
Healthpeak Properties, Inc. (NYSE:DOC) is one of the 10 Fastest Growing S&P 500 Stocks to Buy Now. On May 13, 2026, Baird analyst Wesley Golladay raised the firm’s price target on Healthpeak Properties, Inc. (NYSE:DOC) to $21 from $19 while maintaining an Outperform rating on the shares. The firm updated its model following the company’s […]
REITs present attractive value, thanks in part to a shortage of new supply and relative immunity to AI disruption, and are outperforming the S&P YTD. Read our list of investment picks here.
RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $20 to $21.
With a 6.3% yield, REIT stock HealthPeak Properties is among the highest-paying players in the S&P 500, well above the current 1% average.
With a 6.3% yield, REIT stock HealthPeak Properties is among the highest-paying players in the S&P 500, well above the current 1% average.
Not all REITs ralliedâsee laggards like farmland, mortgage, lab & self-storage, plus steady sectors and M&A support.
Healthpeak Properties trades at 11x P/FFO with a 6% yield, supported by strong capital and segment growth. Read my analysis of DOC stock here.
REIT Q1 earnings beat forecasts as 59% raised FFO guidance; property trends improve and M&A heats up. Read the full analysis here.
UBS maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $17 to $19.
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $19 to $21.
Indexes for US equity real estate investment trusts continued to tick up during the week ended May 8. Read more here.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| DOC | +16.63% | +8.62% | +19.09% | +9.99% |
| XLRE | -0.74% | +0.16% | +9.02% | +5.42% |
| Alpha (stock − sector) | +17.37% | +8.46% | +10.07% | +4.58% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 48.50M | $796.86M | 0.03% | Trimmed-1.8% | 2026-03-31 |
| FidelityFMR | fundamental | 9.26M | $152.16M | 0.01% | Trimmed-12.1% | 2026-03-31 |
| RenTech | quant | 813.6K | $13.37M | 0.02% | Added+45.8% | 2026-03-31 |
| TwoSigma | quant | 483.6K | $7.95M | 0.01% | New | 2026-03-31 |
| Wellington | fundamental | 51.2K | $840.51K | 0.00% | Trimmed-9.5% | 2026-03-31 |
| Bridgewater | macro | 27.5K | $452.38K | 0.00% | New | 2026-03-31 |
| TRowePrice | fundamental | 1.01M | $16.52K | 0.00% | Trimmed-1.2% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | Brinker Scott M | President and CEO | G Gift(deriv) | 60,186 | — | +$0 |
| 2026-05-13 | Bohn Scott R | CDO and Head of Lab | S Open-market sale | 10,989 | $19.45 | −$213.7K |
| 2026-05-07 | Sandstrom Katherine M | Director | A Grant / award | 9,744 | — | +$0 |
| 2026-05-07 | Cartwright Brian G. | Director | A Grant / award | 9,744 | — | +$0 |
| 2026-05-07 | Connor James B. | Director | A Grant / award | 9,744 | — | +$0 |
| 2026-05-07 | Lewis Sara Grootwassink | Director | A Grant / award | 9,744 | — | +$0 |
| 2026-05-07 | Lias-Booker Ava | Director | A Grant / award | 9,744 | — | +$0 |
| 2026-05-07 | Weiss Richard A. | Director | A Grant / award | 9,744 | — | +$0 |
| 2026-05-07 | Griffin R Kent Jr | Director | A Grant / award | 9,744 | — | +$0 |
| 2026-02-17 | Alonso Lisa A | EVP and Chief HR Officer | F Tax withholding | 808 | $16.70 | −$13.5K |
| 2026-02-17 | Alonso Lisa A | EVP and Chief HR Officer | F Tax withholding | 495 | $16.70 | −$8.3K |
| 2026-02-10 | Alonso Lisa A | EVP and Chief HR Officer | F Tax withholding | 657 | $16.85 | −$11.1K |
| 2026-02-10 | Thomas John T | Director | F Tax withholding | 6,454 | $16.85 | −$108.7K |
| 2026-02-10 | Thomas John T | Director | A Grant / award | 23,739 | — | +$0 |
| 2026-01-30 | Alonso Lisa A | EVP and Chief HR Officer | F Tax withholding | 252 | $17.71 | −$4.5K |
| 2026-01-30 | Alonso Lisa A | EVP and Chief HR Officer | A Grant / award | 3,828 | — | +$0 |
| 2026-01-30 | Alonso Lisa A | EVP and Chief HR Officer | A Grant / award | 456 | — | +$0 |
| 2026-01-30 | Bohn Scott R | CDO and Head of Lab | A Grant / award(deriv) | 28,200 | — | — |
| 2026-01-30 | Bohn Scott R | CDO and Head of Lab | A Grant / award(deriv) | 2,396 | — | — |
| 2026-01-30 | Brinker Scott M | President and CEO | A Grant / award(deriv) | 152,067 | — | — |
| 2026-01-30 | Brinker Scott M | President and CEO | A Grant / award(deriv) | 14,133 | — | — |
| 2026-01-30 | Johnston Shawn G | EVP and CAO | A Grant / award(deriv) | 15,462 | — | — |
| 2026-01-30 | Johnston Shawn G | EVP and CAO | A Grant / award(deriv) | 1,198 | — | — |
| 2026-01-30 | Mabry Adam G | CIO | A Grant / award(deriv) | 31,575 | — | — |
| 2026-01-30 | Mabry Adam G | CIO | A Grant / award(deriv) | 2,156 | — | — |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-23upcoming | 0.06 | — | — |
| 2026-05-05 | 0.05 | 0.28 | +456.66% |
| 2026-02-02 | 0.06 | 0.10 | +59.33% |
| 2025-10-23 | 0.06 | -0.18 | -403.17% |
| 2025-07-24 | 0.06 | 0.06 | +12.22% |
| 2025-04-24 | 0.05 | 0.06 | +40.67% |
| 2025-02-03 | 0.06 | 0.01 | -83.51% |
| 2024-10-24 | 0.05 | 0.05 | -8.60% |
| 2024-07-25 | 0.09 | 0.05 | -47.89% |
| 2024-04-25 | 0.05 | 0.09 | +90.89% |
| 2024-02-08 | 0.10 | 0.15 | +45.70% |
| 2023-10-30 | 0.08 | 0.12 | +45.13% |
| 2023-07-27 | 0.10 | 0.09 | -8.40% |
| 2023-04-27 | 0.08 | 0.07 | -17.41% |
| 2023-02-07 | 0.11 | 0.02 | -76.95% |
| 2022-11-01 | 0.12 | 0.10 | -17.64% |